Claudie Charbonneau
-
- Antibiotic Use and Resistance 12
-
- Renal cell carcinoma treatment 20
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 7
- Cancer Research top 5%
- Clinical Biochemistry top 5%
-
- Economic and Financial Impacts of Cancer 19
- Health Systems, Economic Evaluations, Quality of Life 12
-
- Antifungal resistance and susceptibility 18
- Antimicrobial Resistance in Staphylococcus 10
-
- Fungal Infections and Studies 13
- Co-authors
- Jim Z. LiJeffrey D. MillerMason W. RussellKiran GuptaJennifer StephensDilip NathwaniDella VargheseStéphan Martin
- Journals
- Journal of Clinical Oncology (8 papers)SHILAP Revista de lepidopterología (2 papers)Cancer (1 paper)
- Partner nations
- United StatesFranceUnited Kingdom
In The Last Decade
Claudie Charbonneau
65 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Applied Microbiology and Biotechnology 367
- Pulmonary and Respiratory Medicine 962
- Molecular Medicine 137
- Cancer Research 338
- Clinical Biochemistry 127
Countries citing papers authored by Claudie Charbonneau
This map shows the geographic impact of Claudie Charbonneau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudie Charbonneau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudie Charbonneau more than expected).
Fields of papers citing papers by Claudie Charbonneau
This network shows the impact of papers produced by Claudie Charbonneau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudie Charbonneau. The network helps show where Claudie Charbonneau may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claudie Charbonneau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System | 2022 | 3 |
| 2 | 2020 | 0 | |
| 3 | 2020 | 11 | |
| 4 | 2019 | 3 | |
| 5 | 2019 | 16 | |
| 6 | 2018 | 2 | |
| 7 | 2018 | 0 | |
| 8 | 2018 | 3 | |
| 9 | 2017 | 2 | |
| 10 | Economic analysis of empiric versus diagnostic-driven strategies for immunocompromised patients with suspected fungal infections in the People's Republic of China | 2016 | 3 |
| 11 | 2016 | 3 | |
| 12 | 2016 | 8 | |
| 13 | 2015 | 10 | |
| 14 | 2015 | 13 | |
| 15 | 2014 | 16 | |
| 16 | 2013 | 5 | |
| 17 | 2010 | 46 | |
| 18 | 2008 | 3 | |
| 19 | Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature reviewbreakdown → | 2008 | 774 |
| 20 | 2007 | 24 |
About Claudie Charbonneau
Claudie Charbonneau is a scholar working on Applied Microbiology and Biotechnology, Infectious Diseases and Molecular Medicine, having authored 70 papers that have together received 2.2k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (20 papers), Economic and Financial Impacts of Cancer (19 papers), Antifungal resistance and susceptibility (18 papers), Fungal Infections and Studies (13 papers), Antibiotic Use and Resistance (12 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Antimicrobial Resistance in Staphylococcus (10 papers) and Antibiotic Resistance in Bacteria (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (367 citations), Pulmonary and Respiratory Medicine (962 citations) and Molecular Medicine (137 citations). Claudie Charbonneau has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Jim Z. Li, Jeffrey D. Miller, Mason W. Russell, Kiran Gupta, Jennifer Stephens, Dilip Nathwani, Della Varghese, Stéphan Martin, Wajeeha Ansari and Robert J. Motzer. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.